Cargando…
Evaluation of cancer risk in patients with periodontal diseases
BACKGROUND/AIM: In this study, we aimed to assess the cancer risk among patients with periodontal disease. MATERIALS AND METHODS: Patients diagnosed with periodontal diseases at Hacettepe University between 2007 and 2012 were included and data on the diagnosis of any cancer after periodontal disease...
Autores principales: | GÜVEN, Deniz Can, DİZDAR, Ömer, AKMAN, Abdullah Cevdet, BERKER, Ezel, YEKEDÜZ, Emre, CEYLAN, Furkan, BAŞPINAR, Batuhan, AKBIYIK, Ilgın, AKTAŞ, Burak Yasin, YÜCE, Deniz, ERMAN, Mustafa, HAYRAN, Mutlu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Scientific and Technological Research Council of Turkey
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018248/ https://www.ncbi.nlm.nih.gov/pubmed/31195790 http://dx.doi.org/10.3906/sag-1812-8 |
Ejemplares similares
-
Reproductive cancer risk factors among relatives of cancer patients in a tertiary oncology center
por: Atta, Nooria, et al.
Publicado: (2019) -
Comparison of Clinical and Pathological Factors Affecting Early and Late Recurrences in Patients with Operable Breast Cancer †
por: Yekedüz, Emre, et al.
Publicado: (2022) -
Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia
por: Aktaş, Burak Yasin, et al.
Publicado: (2023) -
The platelet to lymphocyte ratio predicts overall survival better than the neutrophil to lymphocyte ratio in metastatic renal cell carcinoma
por: AKTEPE1, Oktay Halit, et al.
Publicado: (2021) -
1612P Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy
por: Guven, D.C.C., et al.
Publicado: (2022)